Early bactericidal activity of new drug regimens for tuberculosis - Authors' reply

Comment

Andreas H Diacon et al. Lancet. 2013.

. 2013 Jan 12;381(9861):112-3.

doi: 10.1016/S0140-6736(13)60042-2.

No abstract available

Comment on

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, Donald PR, van Niekerk C, Everitt D, Winter H, Becker P, Mendel CM, Spigelman MK. Diacon AH, et al. Lancet. 2012 Sep 15;380(9846):986-93. doi: 10.1016/S0140-6736(12)61080-0. Epub 2012 Jul 23. Lancet. 2012. PMID: 22828481 Clinical Trial.
Early bactericidal activity of new drug regimens for tuberculosis.
Wallis RS, Nacy C. Wallis RS, et al. Lancet. 2013 Jan 12;381(9861):111-2. doi: 10.1016/S0140-6736(13)60041-0. Lancet. 2013. PMID: 23312744 No abstract available.
Early bactericidal activity of new drug regimens for tuberculosis.
Mohapatra PR, Chikkahonnaiah P, Aggarwal D. Mohapatra PR, et al. Lancet. 2013 Jan 12;381(9861):111. doi: 10.1016/S0140-6736(13)60039-2. Lancet. 2013. PMID: 23312745 No abstract available.
Early bactericidal activity of new drug regimens for tuberculosis.
Udwadia Z. Udwadia Z. Lancet. 2013 Jan 12;381(9861):111. doi: 10.1016/S0140-6736(13)60040-9. Lancet. 2013. PMID: 23312746 No abstract available.